Lv51
1140 积分 2021-10-22 加入
Recent developments on using pyruvate kinase activators as a new approach for treating sickle cell disease
6天前
已完结
Recent developments on using pyruvate kinase activators as a new approach for treating sickle cell disease
6天前
已关闭
Inherited disorders of hemoglobin: A review of old and new diagnostic methods
10天前
已完结
Luspatercept for the treatment of anaemia in non-transfusion-dependent β-thalassaemia (BEYOND): a phase 2, randomised, double-blind, multicentre, placebo-controlled trial
19天前
已完结
Luspatercept for non‐deletional hemoglobin H disease
19天前
已完结
OVERVIEW ON THALASSEMIA: A REVIEW ARTICLE
20天前
已关闭
Mitapivat sulfate. Pyruvate kinase isozyme R activator, Treatment of pyruvate kinase deficiency, Treatment of thalassemia, Treatment of sickle cell disease
21天前
已完结
Safety and efficacy of mitapivat, an oral pyruvate kinase activator, in adults with non-transfusion dependent α-thalassaemia or β-thalassaemia: an open-label, multicentre, phase 2 study
21天前
已完结
Hemoglobinopathies in the Neonate
21天前
已关闭
皖公网安备34019202002308
